Next Science Limited
NXSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20,414 | $49,160 | $88,902 | $177,195 |
| - Cash | $1,674 | $9,239 | $7,482 | $6,979 |
| + Debt | $2,493 | $962 | $1,220 | $275 |
| Enterprise Value | $21,234 | $40,883 | $82,640 | $170,490 |
| Revenue | $22,816 | $22,179 | $11,713 | $8,948 |
| % Growth | 2.9% | 89.4% | 30.9% | – |
| Gross Profit | $18,443 | $16,235 | $11,905 | $5,939 |
| % Margin | 80.8% | 73.2% | 101.6% | 66.4% |
| EBITDA | -$9,029 | -$14,422 | -$11,776 | -$9,219 |
| % Margin | -39.6% | -65% | -100.5% | -103% |
| Net Income | -$10,586 | -$24,513 | -$18,296 | -$9,029 |
| % Margin | -46.4% | -110.5% | -156.2% | -100.9% |
| EPS Diluted | -0.036 | -0.07 | -0.087 | -0.048 |
| % Growth | 47.8% | 20% | -82.9% | – |
| Operating Cash Flow | -$7,963 | -$15,059 | -$17,007 | -$7,981 |
| Capital Expenditures | -$589 | -$884 | -$686 | -$692 |
| Free Cash Flow | -$8,553 | -$15,943 | -$17,693 | -$8,673 |